Lakdja F, Parienté F, Cros P, Dutin V, Lobera A, Monnin D, Roubault N, Thonnier C
Département d'Anesthésie-Réanimation-Algologie, Centre Régional de Lutte Contre le Cancer, Bordeaux.
Cah Anesthesiol. 1995;43(6):583-6.
Allowing a suffering patient with cancer to control his pain is a challenge that numerous medical teams intend to take up. Although the best treatment is the etiologic one, in many situations the symptomatic and adjuvant therapies are both indispensable. Among them, the patient controlled analgesia (PCA) is a concept referring to the management of the pain, but also to the administration of some analgesic drugs. Even with genuine advantages the limits of the PCA do exist and need to be well known. PCA is not limited to palliative treatment; it can be used in many circonstances during each evolutionary step of the cancer, temporarily or for longer periods, at the hospital and at home as well. All patients disposing of such an equiment could determine their own best level of analgesia, at the good time, depending upon the temporal variability of the pain and its previsibility or not. The availability and the pedagogic concern of the members of the team, the link between the patient and his family, the involvement of both the regular general practioner and the "algologic" team are essential to maintain the best effects of this method.
让身患癌症的痛苦患者控制自身疼痛是众多医疗团队都打算迎接的一项挑战。尽管最佳治疗方法是针对病因的治疗，但在许多情况下，对症治疗和辅助治疗都不可或缺。其中，患者自控镇痛（PCA）是一个不仅涉及疼痛管理，还涉及某些镇痛药给药的概念。即使PCA有诸多真正的优势，其局限性确实存在且需要被充分了解。PCA并不局限于姑息治疗；在癌症的每个发展阶段，它都可在许多情况下使用，无论是短期还是长期，在医院和家中均可。所有配备这种设备的患者都可以根据疼痛的时间变化及其可预测性与否，在合适的时间确定自己的最佳镇痛水平。团队成员的可提供性和教学关怀、患者与其家人之间的联系、普通全科医生和“疼痛治疗”团队的参与，对于维持该方法的最佳效果至关重要。
